相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
TP53 mutational status is predictive of pazopanib response in advanced sarcomas
K. Koehler et al.
ANNALS OF ONCOLOGY (2016)
Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas†
M. Agulnik et al.
ANNALS OF ONCOLOGY (2013)
Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor
Stephen J. Murphy et al.
GASTROENTEROLOGY (2013)
The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
Pavla Brachova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen
C. F. Verschraegen et al.
ANNALS OF ONCOLOGY (2012)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M. Candelaria et al.
ANNALS OF ONCOLOGY (2007)
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
Robert G. Maki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epigenetics as a mechanism driving polygenic clinical drug resistance
RM Glasspool et al.
BRITISH JOURNAL OF CANCER (2006)
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
DZ Qian et al.
CLINICAL CANCER RESEARCH (2006)
CpG island methylation of DNA damage response genes in advanced ovarian cancer
JM Teodoridis et al.
CANCER RESEARCH (2005)
Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas
DR D'Adamo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
Alma Chavez-Blanco et al.
MOLECULAR CANCER (2005)
Valproic acid inhibits angiogenesis in vitro and in vivo
M Michaelis et al.
MOLECULAR PHARMACOLOGY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma
A Potti et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis
L Rössig et al.
CIRCULATION RESEARCH (2002)
Complex functions of mutant p53 alleles from human prostate cancer
XB Shi et al.
PROSTATE (2002)
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling
CF Deroanne et al.
ONCOGENE (2002)
Histone acetylation and disease
S Timmermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Patterns of expression and secretion of vascular endothelial growth factor in malignant soft tissue tumours
C Kuhnen et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
分享论文
